Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00763581 · ClinicalTrials.gov registry record
Personal Adherence Evaluation of Medication Use for Adult Bipolar Disorder Patients
A clinical trial of Bipolar Disorder, sponsored by Case Western Reserve University.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT00763581 is a study of Bipolar Disorder that has completed, run by Case Western Reserve University. The registered enrollment target is 20 participants, below the 333-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00763581, a study of Bipolar Disorder, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will attempt to increase understanding of why bipolar disorder patients do or do not take their medications by conducting in-depth interviews with them.
Conditions Studied
Study Locations (1)
Ohio
- Connections - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00763581
The ClinicalTrials.gov registry entry for NCT00763581 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 333-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (94% lower). The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT00763581 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00763581 about?
NCT00763581 is a clinical study titled "Personal Adherence Evaluation of Medication Use for Adult Bipolar Disorder Patients". This study will attempt to increase understanding of why bipolar disorder patients do or do not take their medications by conducting in-depth interviews with them.
What is the current status of trial NCT00763581?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2008-04. Estimated completion is 2009-01.
What conditions does trial NCT00763581 study?
This clinical trial studies the following conditions: Bipolar Disorder.
Who is sponsoring clinical trial NCT00763581?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00763581 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
RECRUITING · Phase 3
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
RECRUITING · Phase 2
-
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
RECRUITING · Phase 2
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.